The quest for a definitive solution to the progressive cellular damage caused by Fabry disease has long been hampered by the logistical and biological limitations of first-generation enzyme replacement therapies. BioMarin Pharmaceutical is now moving to address this challenge by securing global
Spanish regional policy variations provide a robust dataset showing that pharmaceutical spending is a high-leverage tool for managing infectious disease outcomes. The investigation, spearheaded by researchers like Julieta Politi, delves into the correlation between government expenditure on retail
National health strategies often treat the private sector as an afterthought rather than integrating commercial capacity into the early stages of epidemiological planning. This disconnect frequently results in a lopsided healthcare landscape where private clinics and specialized hospitals
To ensure operational flexibility and maintain existing physician partnerships, Surgery Partners will not be designated as a Catholic ministry after its acquisition by HealthSpan Partners. This significant decision marks a strategic pivot for Bon Secours Mercy Health as it navigates the
Twenty-five Weslaco residents will soon receive specialized Patient Care Technician training through a collaborative funding model designed to eliminate financial barriers to education. This ambitious $117,000 workforce development initiative is spearheaded by the Weslaco Economic Development
By the time the merger concludes in the first half of 2025, private placement investors will hold a 50.1% majority stake in the newly formed metabolic pharmaceutical company. This strategic transition marks a pivotal moment for Corxel Pharmaceuticals, the U.S. subsidiary of the Shanghai-based
